Wed, Aug 20, 2014, 10:29 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Pluristem Therapeutics, Inc. Message Board

  • joejoepepitone joejoepepitone Jan 23, 2014 2:58 PM Flag

    150,000 Annual Doses

    Can someone clarify please, ie. "doses" versus patients served:

    -Is this maximum production capability to satisfy the annual needs of 150,000 patients?
    -Does the typical patient require multiple administrations?
    -How much revenue per patient expected to accrue to PSTI?

    Seems like 150,000 annual doses, or 400/patient production output per day is somewhat low for a fully utilized production facility. Need some assistance understanding this more fully.

    If this opportunity becomes reality, it seems that 150,000 patient capacity may be far too little and a new plant will be needed.

    Thanks.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • The new 3-D Expansion Facility in Israel can produce 150,000 doses of PLX Cells Per Year and each Dose is 300 Million Cells. The Dose Required to Treat a Single PAD Patient requires 2- 300 Million Cell Doses Spaced 2-3 Weeks Apart. For Muscle Injury During Hip Replacement We Just Learned Tuesday Will Only Require 1-150 Million Cell Dose. A Single 300 Million Cell Does Will Retail For Approximately $ 6,000.00 and it Cost Pluristem Approximately $ 300.00 To Make That Dose, So As You Can See The Profit Margin is Off-The-Charts ! The Facility in Israel Can Produce Approximately 1 Billion Dollars Worth of PLX Cells Per Year. We Just Recently Learned That Pluristem Has Made The Strategic Decision To Do All of Their Cell Production in Israel, so New Facilities Will Be Built Over There in The Future.

      Sentiment: Strong Buy

 
PSTI
2.625-0.015(-0.57%)Aug 20 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.